SaExten Vena Cava Filter System in Prevention of Pulmonary Embolism

NACompletedINTERVENTIONAL
Enrollment

192

Participants

Timeline

Start Date

August 13, 2020

Primary Completion Date

January 20, 2022

Study Completion Date

September 8, 2022

Conditions
Pulmonary Embolism
Interventions
DEVICE

SaExten vena cava filter system

Subjects will undergo intervention, be implanted with a SaExten filter. The filter will be retrieved within 90 days or indwelled permanently, depending on the existence of thrombosis and the evaluation of the physician.

DEVICE

Denali inferior vena cava filter

Subjects will undergo intervention, be implanted with a Denali filter. The filter will be retrieved within 90 days or indwelled permanently, depending on the existence of thrombosis and the evaluation of the physician.

Trial Locations (16)

100000

Beijing Luhe Hospital, Capital Medical University, Beijing

110000

The People's Hospitai of Liaoning Province, Shenyang

226000

Affiliated Hospital of Nantong University, Nantong

233000

The First Affiliated Hospital of Bengbu Medical College, Bengbu

264000

Yantai Yuhuangding Hospital, Yantai

310000

Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou

410000

Xiangya Hospital of Central South University, Changsha

450000

The First Affiliated Hospital of Zhengzhou University, Zhengzhou

471000

Luoyang Orthopedic-Traumatological Hospital of Henan Province, Luoyang

510000

The First Affiliated Hospital of Sun Yat-sen University, Guangzhou

518000

Shenzhen Second People's Hospital, Shenzhen

541000

Affiliated Hospital of Guilin Medical University, Guilin

545000

Liuzhou Workers' Hospital, Liuzhou

056000

Handan First Hospital, Handan

030000

Shanxi Provincial People's Hospital, Taiyuan

044000

Yuncheng Central Hospital, Yuncheng

All Listed Sponsors
lead

ShenZhen KYD Biomedical Technology Co., Ltd.

INDUSTRY

NCT04948502 - SaExten Vena Cava Filter System in Prevention of Pulmonary Embolism | Biotech Hunter | Biotech Hunter